Our work on the mutational landscape of PMBCL has been published in Blood! This work, which was led by Stacy Hung and Anja Mottok, highlights the IRF-pathway as a putative novel hallmark and the importance of JAK1, RELB and EP300 mutations in driving oncogenic signaling.